GeoVax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 07 2022 - 9:00AM
via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a
biotechnology company specializing in developing human vaccines and
cancer immunotherapies, today announced that its Chairman &
CEO, David Dodd, will present a company overview at the H.C.
Wainwright 24th Annual Global Investment Conference on Monday,
September 12 at 2:30 p.m. Eastern Standard Time.
A webcast of the presentation will be available at the following
link:
https://journey.ct.events/view/883f0eb3-d86b-41c6-906b-33bbce4c006e.
For more information or to schedule a one-on-one meeting with
management, please visit the conference website at:
https://hcwevents.com/annualconference/.
About GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company
developing human vaccines and immunotherapies against infectious
diseases and cancer using novel proprietary platforms. GeoVax’s
product pipeline includes two ongoing Phase 2 clinical trials of
GEO-CM04S1 for COVID-19 as a universal booster vaccine to mRNA
vaccines authorized by the U.S. Food and Drug Administration (FDA)
and as a primary vaccine for use in immunocompromised patients. In
addition to GEO-CM04S1 for COVID-19, GeoVax is developing GEO-CM02
as a pan-coronavirus vaccine. The Company is also conducting a
Phase 1/2 clinical trial of Gedeptin® for treatment of head and
neck cancer. Gedeptin® has been granted orphan drug status by the
FDA. Additional research and development programs include
preventive vaccines against Zika Virus, hemorrhagic fever viruses
(Ebola, Sudan, Marburg, and Lassa) and malaria, as well as
immunotherapies for multiple solid tumors. The Company’s portfolio
of wholly owned, co-owned, and in-licensed intellectual property
stands at over 70 granted or pending patent applications spread
over 20 patent families.
For additional information about GeoVax, visit our website:
www.geovax.com.
Contact:GeoVax Labs,
Inc.investor@geovax.com678-384-7220
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From Mar 2024 to Apr 2024
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From Apr 2023 to Apr 2024